Blood cancer Clinical Trials in Columbus, OH

As of July 2026, 87 paid clinical trials are recruiting for Blood cancer in Columbus, Ohio. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

87 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

for Richter Syndrome

Drug: Polatuzumab Vedotin

4 locations incl. New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18+

Code: NCT04679012·Phase 2·Recruiting

Apply to this trial

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

for Hematopoietic Stem Cell Transplantation

1 location in Columbus

Sponsor: Nationwide Children's Hospital

Sex: All·Age: Up to 30

Code: NCT06082947·Recruiting

Apply to this trial

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

for Acute Myeloid Leukemia

1 location in Columbus

Sponsor: Nationwide Children's Hospital

Sex: All·Age: 1 - 24

Code: NCT05503134·Phase 1, Phase 2·Recruiting

Apply to this trial

Weighted Blanket Use to Reduce Anxiety in Oncology Patients

for Hematopoietic and Lymphoid Cell Neoplasm

1 location in Columbus

Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All·Age: 18+

Code: NCT06089408·Recruiting

Apply to this trial

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

for Cytokine Release Syndrome

Drug: Talquetamab

1 location in Columbus

Sponsor: Naresh Bumma

Sex: All·Age: 18+

Code: NCT07657312·Phase 2·Recruiting·Listed Jun 18, 2026

Apply to this trial

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for Chronic Lymphocytic Leukaemia

13 locations incl. Boston

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06564038·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

30 locations incl. Mobile

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting

Apply to this trial

Conditions in Blood cancer (Columbus, OH)

Acute myeloid leukemia (AML)· 26 Chronic lymphocytic leukemia (CLL)· 17 Multiple myeloma· 15 Myelodysplastic syndromes (MDS)· 13 Hematologic malignancy· 13 Non-Hodgkin lymphoma· 11 Small lymphocytic lymphoma· 10 Leukemia (other)· 9 Diffuse large B-cell lymphoma (DLBCL)· 9 Follicular lymphoma· 9 Mantle cell lymphoma· 9 Acute lymphoblastic leukemia· 5 Myelofibrosis· 5 Chronic myelomonocytic leukemia· 4 Marginal zone lymphoma· 4 Hodgkin lymphoma· 3 Myeloproliferative neoplasm· 2 Burkitt lymphoma· 2